Litcius/Paper detail

Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma

Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi, Michel W.J.M. Wouters, Sydney Ch’ng, Robyn P.M. Saw, Richard A. Scolyer, Bart A. van de Wiel, Bastian Schilling, Georgina V. Long, Christian U. Blank

2021European Journal of Cancer27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineIpilimumabNivolumabMelanomaNeoadjuvant therapyOncologyLymphadenectomyLymph nodeInternal medicineStage (stratigraphy)Primary tumorImmunotherapyMetastasisCancerCancer researchBiologyPaleontologyBreast cancerCutaneous Melanoma Detection and ManagementMelanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers